Breast cancer recurrence may be influenced by starch consumption
Women who buy Canadian Tamoxifen may help themselves battle breast cancer for a fraction of what this medication costs in the U.S.
Women who buy Canadian Tamoxifen may help themselves battle breast cancer for a fraction of what this medication costs in the U.S. Once a patient is considered in remission, she often has to continue monitoring her health in case the malignancy recurs. New research from the University of California, San Diego, suggests that an increase in the amount of starch that a woman eats may boost the likelihood that her breast cancer returns.
The study team analyzed data collected for more than 2,600 women who were being tracked for breast cancer recurrence during an average of seven years. Subjects had annual phone interviews in which they reported everything they ate during the previous 24 hours.
Results showed that, when broken down into quartiles of change in one year, incidence of recurrence was 9.7 percent among those who decreased their starch intake the most. Within the quartile that increased their starch intake the most, rate of recurrence was 14.2 percent, as reported at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium.
The increased risk appeared to be limited to women with lower-grade tumors, the scientists said. Further studies are needed to assess the impact of limiting starch consumption in these patients.
|
